NEW YORK, Jan. 28 (GenomeWeb News) - Affymetrix today reported total revenues of $300 million for fiscal year 2003 and marked its first year of positive cash flow from operations.
Registering provides access to this and other free content.
Already have an account?Login Now.
Researchers suggest that genetic variations could influence the side effects people experience when using synthetic cannabinoids, the International Business Times reports.
An analysis has examined the makeup of researchers on Twitter and what they share, Nature News reports.
At Stat News, Jim Kozubek argues that the Broad Institute is pushing the boundary of what a nonprofit is.
In PNAS this week: gut microbes may affect honeybee weight, phenotype and gene expression changes in DiGeorge syndrome, and more.